![Joseph Damasio](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : - $ au 31/01/2026
Joseph Luis Damasio is currently Chief Financial Officer at Harvard Apparatus Regenerative Technology, Inc. since 2022.
Formerly, Mr. Damasio was Finance Director at Nelipak Corp., Vice President-Finance & Administration at Pressure BioSciences, Inc. in 2012, Chief Financial Officer & VP-Finance at Pressure BioSciences, Inc. from 2017 to 2019, Senior Accountant at BearingPoint, Inc., Auditor at PricewaterhouseCoopers LLP, Controller at XL Hybrids, Inc. from 2019 to 2020, Vice President-Finance at Inhibikase Therapeutics, Inc. from 2021 to 2022, and Controller at Cue Biopharma, Inc. from 2020 to 2021.
Education includes an MBA from Boston College and an undergraduate degree from the University of Massachusetts.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/07/2012 | 20 ( -.--% ) | 0 $ | 31/01/2026 | |
| 21/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Directeur Financier/CFO | 08/08/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Directeur Financier/CFO | 08/08/2022 |
| CUE BIOPHARMA, INC. | Comptroller/Controller/Auditor | 01/10/2021 |
XL Hybrids, Inc.
 XL Hybrids, Inc. Auto Parts: OEMProducer Manufacturing Develops hybrid electric powertrain technology for commercial and municipal fleets | Comptroller/Controller/Auditor | 01/06/2020 |
| PRESSURE BIOSCIENCES, INC. | Directeur Financier/CFO | 22/02/2019 |
| PRESSURE BIOSCIENCES, INC. | Directeur Financier/CFO | 08/08/2012 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Pressure BioSciences, Inc.
 Pressure BioSciences, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes infectious disease diagnostic products | Health Technology |
BearingPoint, Inc.
 BearingPoint, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management and technology consulting services | Commercial Services |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
XL Hybrids, Inc.
XL Hybrids, Inc. Auto Parts: OEMProducer Manufacturing Develops hybrid electric powertrain technology for commercial and municipal fleets | Producer Manufacturing |
Harvard Apparatus Regenerative Technology, Inc.
 Harvard Apparatus Regenerative Technology, Inc. Medical SpecialtiesHealth Technology Engages in the development and commercialization of medical devices | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Nelipak Corp.
 Nelipak Corp. Miscellaneous Commercial ServicesCommercial Services Provides healthcare packaging solutions | Commercial Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
